135 related articles for article (PubMed ID: 38863978)
1. Effect of sacubitril-valsartan on left ventricular remodeling in patients with acute myocardial infarction after primary percutaneous coronary intervention: a systematic review and meta-analysis.
Liu Y; Sun Y; Dai W
Front Pharmacol; 2024; 15():1366035. PubMed ID: 38863978
[TBL] [Abstract][Full Text] [Related]
2. The benefits of sacubitril-valsartan in patients with acute myocardial infarction: a systematic review and meta-analysis.
Xiong B; Nie D; Qian J; Yao Y; Yang G; Rong S; Zhu Q; Du Y; Jiang Y; Huang J
ESC Heart Fail; 2021 Dec; 8(6):4852-4862. PubMed ID: 34716749
[TBL] [Abstract][Full Text] [Related]
3. A systematic review and meta-analysis of sacubitril-valsartan in the treatment of ventricular remodeling in patients with heart failure after acute myocardial infarction.
Zhou X; Zhu H; Zheng Y; Tan X; Tong X
Front Cardiovasc Med; 2022; 9():953948. PubMed ID: 36304540
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of sacubitril/valsartan compared with ACEI/ARB in the treatment of heart failure following acute myocardial infarction: a systematic review and meta-analysis of randomized controlled trials.
Gao J; Zhang X; Xu M; Deng S; Chen X
Front Pharmacol; 2023; 14():1237210. PubMed ID: 37601056
[No Abstract] [Full Text] [Related]
5. Therapeutic effects and safety of early use of sacubitril/valsartan after acute myocardial infarction: a systematic review and meta-analysis.
Zhang L; Yan K; Zhao H; Shou Y; Chen T; Chen J
Ann Palliat Med; 2022 Mar; 11(3):1017-1027. PubMed ID: 35365031
[TBL] [Abstract][Full Text] [Related]
6. Improved heart function and cardiac remodelling following sacubitril/valsartan in acute coronary syndrome with HF.
Liu H; Su Y; Shen J; Jiao Y; Li Y; Liu B; Hou X; Jin Q; Chen Y; Sun Z; Xi Q; Feng B; Fu Z
ESC Heart Fail; 2024 Apr; 11(2):937-949. PubMed ID: 38224955
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of early administration of sacubitril/valsartan after coronary artery revascularization in patients with acute myocardial infarction complicated by moderate-to-severe mitral regurgitation: a randomized controlled trial.
Yin H; Ma L; Zhou Y; Tang X; Li R; Zhou Y; Shi J; Zhang J
Heart Vessels; 2024 Apr; ():. PubMed ID: 38635062
[TBL] [Abstract][Full Text] [Related]
8. Effects of sacubitril-valsartan on heart failure patients with mid-range ejection fractions: A systematic review and meta-analysis.
Qin J; Wang W; Wei P; Huang P; Lin R; Yue J
Front Pharmacol; 2022; 13():982372. PubMed ID: 36353496
[No Abstract] [Full Text] [Related]
9. The Efficacy of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Post Myocardial Infarction: A Meta-Analysis.
Kotak S; Hassan W; Mehmood M; Kumar U; Sagreeka F; Karishma F; Kumari P; Pirya F; Saquib J; Iqbal A; Khan AA; Varrassi G; Khatri M; Kumar S
Cureus; 2023 Oct; 15(10):e46547. PubMed ID: 37933369
[TBL] [Abstract][Full Text] [Related]
10. Effects of sacubitril/valsartan on cardiac reverse remodeling and cardiac resynchronization in patients with acute myocardial infarction.
Yang P; Li X; Wang L; Wu X; Wang C; Li T; Wang H
Front Cardiovasc Med; 2022; 9():1059420. PubMed ID: 36712243
[TBL] [Abstract][Full Text] [Related]
11. Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy.
Shah AM; Claggett B; Prasad N; Li G; Volquez M; Jering K; Cikes M; Kovacs A; Mullens W; Nicolau JC; Køber L; van der Meer P; Jhund PS; Ibram G; Lefkowitz M; Zhou Y; Solomon SD; Pfeffer MA
Circulation; 2022 Oct; 146(14):1067-1081. PubMed ID: 36082663
[TBL] [Abstract][Full Text] [Related]
12. Effects and Safety of Sacubitril/Valsartan for Patients with Myocardial Infarction: A Systematic Review and Meta-Analysis.
Liu L; Ding X; Han Y; Lv J
J Healthc Eng; 2022; 2022():7840852. PubMed ID: 35035857
[TBL] [Abstract][Full Text] [Related]
13. The Safety and Efficacy of the Early Use of Sacubitril/Valsartan After Acute Myocardial Infarction: A Meta-Analysis of Randomized Controlled Trials.
- A; Rashid M; Soto CJ; Virk GS; Mekowulu FC; Chaudhari SS; Batool S; Usama M
Cureus; 2024 Feb; 16(2):e53784. PubMed ID: 38465175
[TBL] [Abstract][Full Text] [Related]
14. The effect of Sacubitril/Valsartan on cardiac function and cardiac remodeling in patients with heart failure with reduced ejection fraction.
Chen F; Tian G; Bai X; Li J; Yuan Z
Ann Palliat Med; 2021 Aug; 10(8):8684-8691. PubMed ID: 34488357
[TBL] [Abstract][Full Text] [Related]
15. Study on the application effect of bisoprolol combined with sacubitril valsartan sodium tablets in the cardiac rehabilitation of patients with acute myocardial infarction combined with left heart failure after percutaneous coronary intervention (PCI).
Chen C; Wu X; Li Y; Peng Y
Ann Palliat Med; 2021 May; 10(5):5455-5461. PubMed ID: 34044572
[TBL] [Abstract][Full Text] [Related]
16. Effect of sacubitril/valsartan and ACEI/ARB on glycaemia and the development of diabetes: a systematic review and meta-analysis of randomised controlled trials.
Wang R; Ye H; Zhao Y; Wei J; Wang Y; Zhang X; Wang L
BMC Med; 2022 Dec; 20(1):487. PubMed ID: 36527023
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of sacubitril/valsartan vs. valsartan in patients with acute myocardial infarction: A meta-analysis.
Yang P; Han Y; Lian C; Wu X
Front Cardiovasc Med; 2022; 9():988117. PubMed ID: 36093128
[TBL] [Abstract][Full Text] [Related]
18. Effects of sacubitril/valsartan in ESRD patients undergoing hemodialysis with HFpEF.
Guo Y; Ren M; Wang T; Wang Y; Pu T; Li X; Yu L; Wang L; Liu P; Tang L
Front Cardiovasc Med; 2022; 9():955780. PubMed ID: 36440034
[TBL] [Abstract][Full Text] [Related]
19. Combination pharmacotherapies for cardiac reverse remodeling in heart failure patients with reduced ejection fraction: A systematic review and network meta-analysis of randomized clinical trials.
Bao J; Kan R; Chen J; Xuan H; Wang C; Li D; Xu T
Pharmacol Res; 2021 Jul; 169():105573. PubMed ID: 33766629
[TBL] [Abstract][Full Text] [Related]
20. Effect of Emergency Percutaneous Coronary Intervention Combined with Sacubitril and Valsartan on the Cardiac Prognosis in Patients with Acute Myocardial Infarction.
Fan H; Wang Y; Wang X; Dong X; Shao X; Yang F
Int J Gen Med; 2023; 16():499-505. PubMed ID: 36785558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
